COSMOS Pharmaceutical Corporation (TYO:3349)
7,405.00
+46.00 (0.63%)
Oct 22, 2025, 11:30 AM JST
COSMOS Pharmaceutical Revenue
COSMOS Pharmaceutical had revenue of 272.39B JPY in the quarter ending August 31, 2025, with 4.03% growth. This brings the company's revenue in the last twelve months to 1.02T, up 3.73% year-over-year. In the fiscal year ending May 31, 2025, COSMOS Pharmaceutical had annual revenue of 1.01T with 4.81% growth.
Revenue (ttm)
1.02T
Revenue Growth
+3.73%
P/S Ratio
0.57
Revenue / Employee
179.01M
Employees
5,709
Market Cap
583.25B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
May 31, 2025 | 1.01T | 46.40B | 4.81% |
May 31, 2024 | 964.99B | 137.29B | 16.59% |
May 31, 2023 | 827.70B | 72.28B | 9.57% |
May 31, 2022 | 755.41B | 28.99B | 3.99% |
May 31, 2021 | 726.42B | 42.02B | 6.14% |
May 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
May 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
May 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
May 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
May 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Takeda Pharmaceutical Company | 4.48T |
Otsuka Holdings | 2.40T |
Astellas Pharma | 1.94T |
Daiichi Sankyo Company | 1.92T |
Chugai Pharmaceutical | 1.20T |
Terumo | 1.04T |
Olympus | 969.02B |
HOYA Corporation | 876.09B |